[EN] CLASS OF BENZOMORPHOLINE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF [FR] CLASSE DE COMPOSÉS DE BENZOMORPHOLINE, ET PROCÉDÉ DE PRÉPARATION ET UTILISATION DE CELLE-CI [ZH] 一类苯并吗啉类化合物及其制备方法和用途
[EN] CLASS OF BENZOMORPHOLINE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF [FR] CLASSE DE COMPOSÉS DE BENZOMORPHOLINE, ET PROCÉDÉ DE PRÉPARATION ET UTILISATION DE CELLE-CI [ZH] 一类苯并吗啉类化合物及其制备方法和用途
Silver-Catalyzed Formal Insertion of Arynes into R<sub>f</sub>I Bonds
作者:Yuwen Zeng、Jinbo Hu
DOI:10.1002/chem.201402846
日期:2014.6.2
An unprecedented silver‐catalyzed formal insertion of arynes into RfI (Rf=CF3, C2F5) bonds has been developed. This protocol provides easy access to various ortho‐perfluoroalkyl iodoarenes under mild conditions. In this insertion reaction, an ionic atom‐transfer reaction of RfI occurs, and a silver‐mediated metathesis process is involved in the efficient transfer of the electropositive iodine atom
Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same
申请人:Hoveyda Hamid R.
公开号:US20110105389A1
公开(公告)日:2011-05-05
The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (GRLN, growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and/or variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as antagonists or inverse agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, obesity and obesity-associated disorders, appetite or eating disorders, addictive disorders, cardiovascular disorders, gastrointestinal disorders, genetic disorders, hyperproliferative disorders, central nervous system disorders and inflammatory disorders.
[EN] UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS D'ISOXAZOLE CONTENANT DE L'URÉE UTILISÉS COMME AGONISTES DE FXR ET LEURS PROCÉDÉS D'UTILISATION
申请人:ENANTA PHARM INC
公开号:WO2018081285A1
公开(公告)日:2018-05-03
The present invention provides compounds of Formula (I), Pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR- mediated or TGR5-mediated diseases or conditions.
[EN] CLASS OF BENZOXAZINE SPIRO COMPOUNDS AND PREPARATION METHOD THEREFOR<br/>[FR] CLASSE DE COMPOSÉS SPIRO DE BENZOXAZINE ET PROCÉDÉ DE PRÉPARATION CORRESPONDANT<br/>[ZH] 一类苯并噁嗪螺环类化合物及其制备方法